title: The utility of screening in the design of trials for symptom management in cancer.
abstract: Clinical trials that test interventions for symptom management must target patients whose symptoms are severe and can benefit from participation. Screening symptoms for their severity prior to trial entry may be an important element of trial design. This research describes the utility of screening for severity of symptoms prior to entry into clinical trials for symptom management in cancer. To accomplish this, 601 cancer patients undergoing chemotherapy were assessed at screening and at the initial intervention contact, using the 0-10 rating scale for severity of nine symptoms. Post-test probabilities and likelihood ratios (LRs) were estimated across cut-offs in screening severity scores. Areas under receiver operating characteristic curves for reaching threshold of four at the initial intervention contact were estimated by a nonparametric method. It was found that screening severity scores were good predictors for identifying patients who would not reach threshold but did not always accurately predict patients who would. The cut-offs between 2 and 4 on a 0-10 scale could be used to identify patients that might benefit from receipt of interventions. For all symptoms, the LRs were greater than one across possible screening cut-offs. The findings indicate that decision rules based on screening prior to entry into cancer symptom management trials can provide reasonable discriminative accuracy by differentiating among patients who are likely to reach higher levels of severity later in the trial from those who are not. Optimal severity cut-offs can be established based on LRs and desired sensitivity and specificity.
authors.affiliation: School of Nursing, Yale University, New Haven, Connecticut, USA.
authors.forename: Sangchoon
authors.initials: S
authors.lastname: Jeon
authors.forename: Charles W
authors.initials: CW
authors.lastname: Given
authors.forename: Alla
authors.initials: A
authors.lastname: Sikorskii
authors.forename: Barbara
authors.initials: B
authors.lastname: Given
mesh_terms: D000368:Aged; D020000:Decision Support Systems, Clinical; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D009369:Neoplasms / Q000175:diagnosis* / Q000451:nursing*; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D014481:United States / Q000453:epidemiology
references.citation: J Clin Oncol. 2006 Sep 20;24(27):4485-91
references.pmid: 16983118
references.citation: Am J Epidemiol. 2006 Apr 1;163(7):670-5
references.pmid: 16410346
references.citation: J Pain Symptom Manage. 2000 Aug;20(2):104-12
references.pmid: 10989248
references.citation: Cancer Pract. 1994 Jan-Feb;2(1):57-62
references.pmid: 8055007
references.citation: Oncol Nurs Forum. 2001 Apr;28(3):465-70
references.pmid: 11338755
references.citation: J Natl Compr Canc Netw. 2003 Jul;1(3):308-31
references.pmid: 19761067
references.citation: Clin J Oncol Nurs. 2007 Oct;11(5):659-66
references.pmid: 17962174
references.citation: Cancer. 1999 Oct 15;86(8):1609-20
references.pmid: 10526293
references.citation: Support Care Cancer. 2006 Aug;14(8):825-30
references.pmid: 16491377
references.citation: J Pain Symptom Manage. 2003 Apr;25(4):307-18
references.pmid: 12691682
references.citation: Ann Intern Med. 2001 May 1;134(9 Pt  2):844-53
references.pmid: 11346320
references.citation: Cancer. 2003 Jun 1;97(11):2880-6
references.pmid: 12767103
references.citation: Support Care Cancer. 2006 Aug;14(8):792-4
references.pmid: 16565822
references.citation: Cancer. 1999 Mar 1;85(5):1186-96
references.pmid: 10091805
references.citation: Semin Hematol. 1997 Jul;34(3 Suppl 2):4-12
references.pmid: 9253778
references.citation: Cancer. 2000 Oct 1;89(7):1634-46
references.pmid: 11013380
references.citation: Ann Intern Med. 2001 May 1;134(9 Pt 1):783-5
references.pmid: 11329237
references.citation: J Natl Cancer Inst. 2005 Mar 16;97(6):448-56
references.pmid: 15770009
references.citation: Eur J Cancer. 2005 Jan;41(2):199-205
references.pmid: 15661543
references.citation: Pain. 2004 May;109(1-2):132-42
references.pmid: 15082135
references.citation: Radiology. 1982 Apr;143(1):29-36
references.pmid: 7063747
references.citation: Oncologist. 2000;5(5):353-60
references.pmid: 11040270
references.citation: Cancer Invest. 2005;23(3):229-39
references.pmid: 15945509
references.citation: J Palliat Care. 2002 Fall;18(3):150-9
references.pmid: 12418365
references.citation: J Pain Symptom Manage. 2001 Jun;21(6):456-66
references.pmid: 11397603
references.citation: Prev Vet Med. 2000 May 30;45(1-2):23-41
references.pmid: 10802332
references.citation: J Clin Epidemiol. 1999 Sep;52(9):885-92
references.pmid: 10529029
references.citation: J Natl Cancer Inst Monogr. 2004;(32):17-21
references.pmid: 15263036